1 Avenue de Lafayette,

Boston,

MA,

US,

ZIP: 02111

Phone: 1 617 455 4188

The 2nd annual Dermatology Drug Development Summit provides a unique forum for industry leaders to take advantage of this tremendous environment of opportunity driven by huge investments to innovate and bring better and more efficient drugs to market, for the treatment of high unmet need.

Leading organizations and experts in this space will share their exclusive insight in an end-to-end discussion sharing pharmaceutical best practice and the latest case-studies on the development and bringing to market of new and innovative dermatological drugs.

Join them to collaboratively tackle specific challenges you face in developing these drugs – from strategic concerns, to discovery, preclinical activities, formulation and delivery strategies, biologic therapies, clinical development, regulatory and commercial hurdles – and uncover the details behind the latest developments in this space.

Tickets    https://go.evvnt.com/265318-1?pid=1052
Brochure https://go.evvnt.com/265318-2?pid=1052

Prices:
Conference (Standard)    USD 2799.0
Conference (Early bird discount ends Friday September 21, 2020)    USD 2599.0
Conference (Early bird discount ends Friday October 19, 2020)    USD 2699.0

Category: Conferences | Science, Health & Medicine | Pharmaceuticals

Speakers: Betsy Hughes-Formella,,Independent Consultant,Dermatology Drug Development,Cary Schockemoehl,,VP, Business Development & Strategy,,Realm Therapeutics, Inc.,Conrad Winters,Director, Product Development,,CPL,Dan Piacquadio,President, CEO & Founder,,Therapeutics Inc.,Dogan Fidan,Head of Global Strategic Franchise Immunology & Inflammation,Galderma, Edward Hsia,VP, External Research & Innovation,Almirall,Frank Nestle,Global Head, Immunology Therapeutic Research Area & CSO North America,Sanofi,Frédérique Menzaghi,Senior VP, R&D,Cara Therapeutics, Inc,Hans Hofland,VP – Research & Nonclinical,Development,Dermira,Iain Stuart,Senior VP, R&D,Foamix Pharmaceuticals, Inc.,James Cassella,Chief Development Officer,Concert Pharmaceuticals,Jasmina Jankicevic,Dermatologist,Clinical Development & Medical Affairs Consulting,Jean-Philippe Therrien,VP, Skin Biology,EnDev Laboratories,,Tergus Pharma,John Zibert,Medical Director & CMO,LEO Innovation Lab,Jon Lenn,Senior VP, US Operations,MedPharm,Kim D. Kjøeller,,Executive VP, Global R&D,,LEO Pharma A/S,Lee Koetzner,Senior Manager, Preclinical Pharmacology,Castle Creek Pharmaceuticals,Mandeep Kaur,VP & Head of North America Medical Affairs,Sanofi,Mary Spellman,CMO,Menlo Therapeutics Inc,Michael Howell,Senior Director – Translational Research,,Incyte Corporation,Paul Lizzul,CMO,Sienna Biopharmaceuticals,Paul Smith,,Senior Director – Preclinical Pharmacology,Incyte Corporation,Robert Rissmann,Research Director Dermatology,Center for Human Drug Research,Samir Mitragotri,Hiller Professor of Bioengineering & Hansjorg Wyss Professor of Biologically Inspired Engineering,Harvard University,Venkat Reddy,Senior VP & Global Head of Translational Sciences,Glenmark Pharmaceutical,Vijendra Nalamothu,CEO,Tergus Pharma,Weston Daniel,Senior Director – Program Manager,Exicure Inc.